Natural Products Insider is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Tackling Curcumins Formulation Caveats

<p>In order to reap curcumin&#8217;s colorful health benefits, formulators must overcome staining and bioavailability challenges.</p>

The only thing hotter than curcumin’s vivid orange color is its reputation for delivering major anti-inflammatory benefits. Curcumin is the latest “it" ingredient, and while manufacturers are clamoring to incorporate this antioxidant into their products, the caveats associated with its bioavailability and propensity for color staining and bleeding are causing formulators to proceed with caution. Curcumin ingredient suppliers have developed their own methods and tips for formulating with curcumin.

Though commonly used as a natural colorant, curcumin has an inherently messy reputation when it comes to color bleeding and staining during the formulating and production phases. Formulators and ingredient suppliers have a come up with a number of practical solutions to circumvent this problem. The primary issue hampering curcumin beyond color bleeding concerns is its limited bioavailability.

Curcumin is extremely hydrophobic and is not readily absorbed in the human bloodstream—a key factor that limits its use dietary supplements. But ingredient providers have devised novel ways to envelope and protect and preserve the vital beneficial components of this ingredient, protecting curcumin’s bioavailability not just during the production phase but also during the digestive process to ensure the product is metabolized properly so that optimum health benefits can be realized. 

Read “Formulating with Curcumin" in INSIDER’s Curcumin Digital Issue for more on curcumin’s most beneficial delivery forms, and how ingredient suppliers and formulators are responding to FDA’s crackdown on anti-inflammatory claims.

Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.